Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.55% |
| 2 | Financials | 7.82% |
| 3 | Consumer Discretionary | 7.65% |
| 4 | Communication Services | 5.12% |
| 5 | Healthcare | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Colliers International
CIGI
$5.41B
| $565K | ﹤0.01% |
4,328
+2,656
| +159% | +$323K |
|
3427
Camping World
CWH
$675M
| $564K | ﹤0.01% |
32,805
-17,430
| -35% | -$272K |
|
3428
Geron
GERN
$982M
| $562K | ﹤0.01% |
398,775
-721,553
| -64% | -$1.02M |
|
3429
Vital Farms
VITL
$498M
| $561K | ﹤0.01% |
14,564
-12,516
| -46% | -$422K |
|
|
CGAU
3430
Centerra Gold
CGAU
$4.15B
| $561K | ﹤0.01% |
78,030
+5,194
| +7% | +$35.5K |
|
|
BFS
3431
Saul Centers
BFS
$865M
| $560K | ﹤0.01% |
16,410
-5,581
| -25% | -$188K |
|
3432
Banco Bradesco
BBD
$34.3B
| $560K | ﹤0.01% |
181,196
+48,056
| +36% | +$126K |
|
3433
Clover Health Investments
CLOV
$2.38B
| $557K | ﹤0.01% |
199,645
+177,711
| +810% | +$584K |
|
|
PALD
3434
Direxion Daily PANW Bear 1X ETF
PALD
$1.98M
| $557K | ﹤0.01% |
25,000
| – | – |
|
3435
Woori Financial
WF
$17.2B
| $556K | ﹤0.01% |
11,178
+872
| +8% | +$34.5K |
|
3436
WisdomTree US MidCap Dividend Fund
DON
$4.11B
| $554K | ﹤0.01% |
11,048
+42
| +0.4% | +$2.03K |
|
|
MRC
3437
DELISTED
MRC Global
MRC
| $554K | ﹤0.01% |
40,380
-47,159
| -54% | -$569K |
|
3438
Columbia India Consumer ETF
INCO
$239M
| $553K | ﹤0.01% |
8,522
+1,124
| +15% | +$71.1K |
|
3439
Redwire
RDW
$3.3B
| $553K | ﹤0.01% |
33,917
+12,199
| +56% | +$159K |
|
3440
Monro
MNRO
$352M
| $552K | ﹤0.01% |
37,051
-18,362
| -33% | -$265K |
|
3441
iShares US Utilities ETF
IDU
$1.38B
| $552K | ﹤0.01% |
5,281
+2,501
| +90% | +$256K |
|
3442
JPMorgan US Quality Factor ETF
JQUA
$8.66B
| $552K | ﹤0.01% |
9,185
+2,830
| +45% | +$162K |
|
3443
State Street SPDR S&P Health Care Equipment ETF
XHE
$169M
| $550K | ﹤0.01% |
6,775
+71
| +1% | +$5.66K |
|
|
OACCU
3444
Oaktree Acquisition Corp III Life Sciences Unit
OACCU
| $550K | ﹤0.01% |
50,900
| – | – |
|
3445
FuboTV Inc
FUBO
$296M
| $548K | ﹤0.01% |
11,826
-12,940
| -52% | -$484K |
|
3446
Diebold Nixdorf
DBD
$2.45B
| $548K | ﹤0.01% |
9,885
-8,354
| -46% | -$392K |
|
3447
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
| $548K | ﹤0.01% |
13,807
-146
| -1% | -$5.5K |
|
|
AHRT
3448
AH Realty Trust
AHRT
$506M
| $546K | ﹤0.01% |
79,493
-33,529
| -30% | -$233K |
|
3449
CALL
Syndax Pharmaceuticals
SNDX
$1.7B
| $546K | ﹤0.01% |
58,300
| – | – |
|
|
3450
PUT
Syndax Pharmaceuticals
SNDX
$1.7B
| $546K | ﹤0.01% |
58,300
| – | – |
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 468 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.